GeneDx Holdings WGS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Business | ||||||
| GeneDx | $101.5M-15.1% | $119.49M+4.2% | $114.7M+12.7% | $101.78M+16.8% | $87.12M-8.6% | |
| Other | $758K— | —— | —— | —— | $0-100% | |
| Adjusted Gross Margin by Business | ||||||
| GeneDx | $69.88M-17.8% | $85M+0.6% | $84.45M+17.6% | $71.82M+20.3% | $59.72M-10.7% | |
| Other | $170K— | —— | —— | —— | $0-100% | |
| Adjusted cost of services by Business | ||||||
| GeneDx | $31.61M-8.4% | $34.49M+14.0% | $30.25M+0.9% | $29.96M+9.4% | $27.4M-3.5% | |
| Other | $588K— | —— | —— | —— | $0-100% | |
| Total Revenue by Product | ||||||
| Institutional customers | $16.09M+1.0% | $15.94M-10.8% | $17.87M-2.8% | $18.38M+4.4% | $17.6M+22.8% | |
| Patients with third-party insurance | $84.92M-16.0% | $101.05M+6.3% | $95.02M+17.2% | $81.1M+19.2% | $68.06M-14.1% | |
| Self-pay patients | $286K-3.7% | $297K-52.8% | $629K+85.5% | $339K+253% | $96K-84.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does GeneDx Holdings break its business down?
- GeneDx Holdings (WGS) reports total revenue by business across 2 parts — GeneDx and Other. Each is extracted from the segment footnotes and tracked over time.
- Where does GeneDx Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in GeneDx Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
